Scott Morano explores some of the challenging questions brands will need to ask in light of an HCP switch to telemedicine.
Scott Morano
Advertisement
Scott Morano is Vice President, Ipsos.
Articles by Scott Morano
Advertisement
Latest Updated Articles
The Truth About TelemedicinePublished: June 4th 2020 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
FDA Approves Libtayo for Immunotherapy for Adjuvant Treatment of Cutaneous Squamous Cell Carcinoma
2
The Situation We Faced: The Development and Commercialization of MariTide
3
Most Favored Nation Order: Legal Battles, Market Shifts, and the Future of Drug Pricing Reform
4
Novo Nordisk Enters $4.7 Billion Definitive Agreement with Akero Therapeutics
5
